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Abstract. We have developed a novel carbon nanotube-based con-
trast agent for both thermoacoustic and photoacoustic tomography. In
comparison to deionized water, single-walled carbon nanotubes ex-
hibited more than twofold signal enhancement for thermoacoustic to-
mography at 3 GHz. In comparison to blood, they exhibited more
than sixfold signal enhancement for photoacoustic tomography at
1064 nm wavelength. The large contrast enhancement of single-
walled carbon nanotubes was further corroborated by tissue phantom
imaging studies. © 2009 Society of Photo-Optical Instrumentation Engineers.
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he advent of numerous noninvasive imaging modalities,
uch as X-ray, computed tomography, single photonemission-
omputed tomography, positron emission tomography PET,
agnetic resonance imaging MRI, ultrasound imaging, ra-
io frequency rf, and optical imaging now allows scientists
nd clinicians to acquire in vivo images of the anatomy and
hysiology of animals and humans.1,2 Each of these in vivo
maging techniques possesses characteristic strengths and
eaknesses. For each imaging modality, substantial attention
as been devoted to developing contrast agents not only for
mproving the contrast of the acquired images, but also for
olecular imaging targeting specific biomolecules, cell track-
ng, and gene expression.3–6
We have developed hybrid imaging modalities, such as
hermoacoustic TA tomography TAT and photoacoustic
PA tomography PAT, for different applications7–11 and
ombined these two imaging modalities into a single imaging
ystem for early breast cancer detection.12 Diagnosis of cancer
n its early stages depends on the recognition of subtle
hanges in tissue properties, such as mechanical properties,
ptical absorption, and rf absorption. For example, changes in
on and water concentrations lead to changes in rf absorption.
o detect these changes, nonionizing rf electromagnetic
ddress all correspondence to: Balaji Sitharaman, Department of Biomedical
ngineering, State University of New York at Stony Brook, Stony Brook,
Y 11794; Tel: 631-632-1810; E-mail: balaji.sitharaman@stonybrook.edu; and
ihong V. Wang, Optical Imaging Laboratory, Department of Biomedical Engi-
eering, Washington University in St. Louis, Campus Box 1097, One Brookings
rive, St. Louis, MO 63130; Tel: 314-935-6152; Fax: 314-935-7448; E-mail:
hwang@biomed.wustl.eduournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usewaves and visible/near infrared NIR light-based imaging
modalities have generated particular interest over the last
decade.7–11,13–17 TAT/PAT synergizes the advantages of pure-
ultrasound and pure-rf/optical imaging,7,13 allowing both sat-
isfactory spatial resolution and high soft-tissue contrast. For
instance, PAT is a unique noninvasive technology for imaging
and quantifying the levels of vascularization and oxygen satu-
ration in tumors.9–11,18,19 These features are associated with
angiogenesis and hypoxia accompanying malignant
tumors.20,21 TAT/PAT is also capable of revealing information
such as water/ion concentration, blood volume, and oxygen-
ation of hemoglobin. Because these parameters can change
during the early stages of cancer, TAT/PAT offers opportuni-
ties for early detection. However, even though high rf and
optical contrast exists between well-developed malignant tu-
mor tissue and normal human breast tissue, the contrast dur-
ing very early stages of cancer may be insufficient. Thus, a
targeted contrast agent could be greatly beneficial for early
cancer diagnosis using TAT/PAT.
Recently, carbon nanotube-based contrast agents have
shown promise for a variety of imaging techniques.22–25 The
strategies for development of these contrast agents have in-
cluded encapsulation of medically relevant metal ions within
their carbon sheath,22 external functionalization of the carbon
sheath with a variety of imaging agents,23,24 and exploiting the
intrinsic physical properties of the carbon nanotubes.25 In this
work, we have explored the intrinsic optical26,27 and rf28 ab-
sorbing properties of single-walled carbon nanotubes
SWNTs with the goal of developing them as multimodal
1083-3668/2009/143/034018/8/$25.00 © 2009 SPIEMay/June 2009  Vol. 1431
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Methods and Materials
.1 TAT/PAT Scanner
combined TAT/PAT scanner12 was used for all the experi-
ental studies in this work. Images were collected with mi-
rowave excitation TAT and then with laser excitation
PAT. For TAT, a 3.0-GHz microwave source with a 0.5-s
ulse width and 100-Hz pulse repetition rate was the rf
ource. The pulse energy was estimated to be around 10 mJ
=20 kW0.5 s, falling within the IEEE safety
tandards.29 PAT was done at 1064 nm wavelength. A
-switched Nd:YAG laser with a 10-Hz pulse repetition rate,
.5-ns at 1064 nm wavelength laser pulse width, and
50-mJ maximal output energy was the light source. The in-
ident laser fluence on the sample surface was controlled to be
20 mJ /cm2, conforming to the American National Stan-
ards Institute ANSI standards.30 The generated acoustic
ignals were detected using two different nonfocused trans-
ucers operating at a 2.25-MHz central frequency
13-mm-diam active area, ISS 2.250.5 COM; 6-mm-diam
ctive area, ISS 2.250.25 COM, Krautkramer. For cross-
ectional TAT/PAT imaging, data were collected around the
ample in a full circle. Different reconstruction algorithms can
e used to reconstruct TAT/PAT images from raw data.16 Here,
delay and sum backprojection algorithm was used for all
mage reconstruction.16 The sample was placed inside the
reast holder chamber, which was filled with mineral oil.
ineral oil does not absorb microwaves. Moreover, because
ineral oil is transparent, the light absorption is also very
mall. Mineral oil also acts as a coupling medium for sound
ropagation. Thus for all our experiments, mineral oil was an
deal choice as a background medium.
.2 PA Imaging System
reflection-mode PA imaging system31 was used to test the in
itro blood signal enhancement using the SWNTs. A tunable
i:sapphire laser LT-2211A, LOTIS TII pumped by a
-switched Nd:YAG LS-2137, LOTIS II laser was the light
ource, providing 15-ns pulse duration and a 10-Hz pulse
epetition rate. A 5-MHz central frequency, spherically fo-
used ultrasonic transducer V308, Panametrics-NDT was
sed to acquire the generated PA signals. The transducer had a
.54-cm focus length, a 1.91-cm-diam active area element,
nd 72% bandwidth. The signal was then amplified by a low-
oise amplifier 5072PR, Panametrics-NDT, and recorded
sing a digital oscilloscope TDS 5054, Tektronix with a 50
ega-sampling rate. PA signal fluctuations due to pulse-to-
ulse energy variation were compensated by signals from a
hotodiode DET110, Thorlabs, which sampled the energy of
ach laser pulse.
.3 SWNTs Synthesis
diblock copolymer templating method was used to coat Fe
oated on Si wafers.32 The wafers were placed in a 3-in.
uartz reaction chamber Easy Tube 2000, First Nano and
eated in Ar to 900 °C. The chamber was filled with H2 for
min, and CH4 was added to the gas flow as the carbon
eedstock for 20 min to initiate the growth of SWNTs. Sub-ournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usesequently, the carbon feedstock was switched off and the fur-
nace was cooled to room temperature. Raman spectroscopy
LabRAM Aramis, Horiba JvonYvon at 633-nm excitation,
transmission electron microscope TEM imaging JEOL
2000 FX electron microscope operating at 200 kV,  poten-
tial Malvern Zetasizer NanoZS system with irradiation from
a 632.8-nm He–Ne laser, and atomic force microscopy
AFM MFD-3D-BIO, Asylum Research were used to char-
acterize the SWNTs.
Figure 1a shows a representative bright-field TEM image
of densely populated SWNTs on the surface of the substrate.
Further investigation by high-resolution TEM HRTEM Fig.
1b and AFM Fig. 1c showed SWNTs with diameters
between 1.2 and 2.2 nm and lengths between 500 nm and
1 m. Figure 1d shows a representative Raman spectrum of
SWNTs at the laser excitation wavelength of 633 nm. The
Raman spectrum shows a G band at 1596 cm−1 and a D band
at 1320 cm−1, with a D/G band ratio for Gd-SWNTs of 0.1,
indicating that the SWNTs have very few defects.33 The radial
breathing modes Fig. 1d inset, unique to SWNTs,33 further
corroborate the HRTEM and AFM results and confirm the
presence of SWNTs. Four types of multiwalled carbon nano-
tubes MWNTs of various inner and outer diameters,
fullerenes Sigma-Aldrich, USA, catalog number 483036,
and graphite microparticles Sigma-Aldrich, catalog number
496596 were also used for initial studies. SWNT suspensions
with different concentrations 0.1–1 mg /mL were prepared
in 10 mL of 1% biologically compatible Pluronic® F127 sur-
factant solution pH 7. The different domains of the nonionic
Pluronic F127 likely wrapped themselves in energy-
minimized conformations around the nanotubes to solubilize
the SWNTs by steric stabilization, producing nearly neutral
nanotube suspensions.34 These suspensions were stable during
the period of the entire study. The -potential measurements
were performed on 0.1 mg /mL SWNTs dispersed in Pluronic
F-127 and showed a peak  potential of −14 mV with a
Gaussian distribution full width half maximum of the
distribution=10 mV. This value is similar to other reported
-potential measurements on neutral stable SWNTs dispersed
in Pluronic F127.34 Figure 1e shows an optical image of the
SWNTs 0.1–1 mg /mL concentration dispersed in Pluronic
F127 after aggressive sonication.
3 Results and Discussions
A low-density polyethylene LDPE vial with an inner diam-
eter of 6 mm and 1 cc volume was used as a sample holder
for the entire study. The vial was filled with the sample and
placed inside the TAT/PAT scanner. Deionized DI water was
used for TA signal comparison, whereas blood was used for
PA signal comparison. Water and ions are two well-known
sources of microwave absorbers in the human body, and they
produce strong TA signals. Therefore, to show that a new
material in this case, SWNTs can function as a contrast
agent, we have to first show that SWNTs are capable of gen-
erating TA signals comparable to or stronger than a known TA
signal producer in the body. The rf contrast between malig-
nant tumor tissue and normal human breast tissue is as high as
4:1.35 The rf absorption of water compared to background
human breast tissue is also on the order of 4:1. Thus, we
compared the rf absorption of SWNTs to that of water. Simi-May/June 2009  Vol. 1432
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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nd produces strong PA signals. Therefore, to show that
WNTs can function as a contrast agent in PA, we must first
how that SWNTs are capable of generating PA signals com-
arable to or stronger than that of a known absorber in the
ody. Blood was thus an obvious choice for comparison here.
or the tissue phantom imaging, porcine fat was used as the
ackground medium mimicking the tissue; the sample holder
LDPE vial was inserted in the center of a 6-cm-diam por-
ine fat cylinder of 1.5 cm high. The vial was filled with
ifferent samples DI water, SWNTs, and blood and images
ere collected. The hole inside the porcine fat had a slightly
arger diameter than the sample holder’s outside diameter.
Figure 2a shows the TA signal generated from the sample
older LDPE vial filled with DI water and with mineral oil.
s we can clearly see, there is no TA signal from the sample
older filled with mineral oil red line, showing only the noise
f the system, no TA signal was observed. Therefore, the
DPE vial does not generate any TA signal. Moreover, the
DPE vial we used is semi-transparent white and, therefore, it
oes not absorb enough light to produce any measurable PA
ignal. Nevertheless, we tested the LDPE vial filled with
lood and mineral oil under 1064-nm wavelength light. Fig-
re 2b shows the PA signal generated from the vial. It is
learly seen that vial filled with mineral oil does not produce
ny significant PA signal at 1064 nm compared to the signal
enerated from blood. Therefore, we conclude that the sample
older vial has no effect either in TA or in PA signal genera-
ion, and henceforth, all signals observed are considered to be
enerated from the sample placed inside the vial. We also
ested the 1% Pluronic F127 surfactant solution and observed
ig. 1 a A low-resolution bright-field TEM, b HRTEM image of bun
f dispersed SWNTs. d D-band and G-band Raman spectra of the SW
ispersions of SWNTs in Pluronic F127 after being sonicated. From left
vi 1 mg/mL. Color online only.ournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Useno significant TA/PA signals. Figure 2c shows the TA signal
generated from the LDPE vial filled with 1% Pluronic F127
surfactant solution and DI water, and there is no significant
contribution from the surfactant solution. Figure 2d shows
the PA signal generated from blood and 1% Pluronic F127
surfactant solution. Clearly, there is no PA signal generated
from 1% Pluronic F127 surfactant solution. Therefore, any
WNTs grown using Fe as the catalyst. c Tapping mode AFM images
he inset shows the radial breathing modes. e Vials contain aqueous
t, the concentrations are i 0, ii 0.1, iii 0.25, iv 0.5, v 0.75, and,
Fig. 2 a TA signals from a LDPE vial i.d. 6 mm, volume 1 cc filled
with mineral oil MO and DI water DI. b PA signals from LDPE
vial filled with blood and MO at 1064 nm. c TA signals from the
LDPE vial filled with 1% Pluronic F127 solution F127 and De-
ionized water DI. d PA signals from a tube Silastic® laboratory
tubing, Dow Corning Corp., with 300 m i.d., 640 m o.d. filled
with blood and with 1% Pluronic F127 solution F127. Color online
only.dled S
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ill be ignored in all future discussion.
An initial assessment was made for all the carbon nano-
tructures SWNTs, MWNTs, C60, and graphite micropar-
icles. Table 1 summarizes the peak-to-peak TA/PA signal
mplitudes obtained from various samples with the two dif-
erent diameter transducers. Among all the samples, only
WNTs showed a significant increase in TA signal compared
o DI water and a significant increase in PA signal compared
o rat blood. To avoid overinterpretation of the data presented
n Table 1, it is important to mention here that the TA and PA
ignals generated from the MWNT are not directly propor-
ional to the outer diameter. Other parameters, such as the
nner diameter, nanotube length, and number of concentric
anotubes, may also affect the generated signal amplitudes.
he only conclusion that can be drawn from Table 1 is that
he SWNT sample generates a PA and TA signal stronger than
hat from blood, water, and other carbon nanostructures. The
ncreases in TA and PA signals were shown by pristine
WNTs mass of Fe is 20% of total weight of the SWNT
ample as well as purified SWNTs mass of Fe is 0.5–1%
f the total weight of the SWNT sample, clearly indicating
hat the observed effects were due to the SWNTs and not due
o the presence of iron. Because only SWNTs showed a sig-
ificant increase in both TA and PA signals, they were used
or further studies.
Figure 3a displays the TA signals from an LDPE vial
lled with DI water and another vial filled with 1-mg /mL
WNTs. The peak-to-peak TA signal amplitudes generated by
I water and 1-mg /mL SWNTs are 420.32 and
Table 1 Peak-to-peak TA/PA signal amplitudes o
volume vial was the sample holder. TA was don
Sample
Peak-to-peak
amplitude
0.5-in. active
area
transducer
Deionized water 47
SWNT
1 mg/mL
95
Fullerene C60 51
Graphite microparticles 38
MWNT
o.d.=10–15 nm
40
Aldrich MW
NT o.d.=20–30 nm
40
MWNT
o.d.=40–70 nm
39
MWNT
o.d.=110–170 nm
47
Blood —ournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Use1010.24 mV, respectively. Figure 3b shows the peak-to-
peak TA signal amplitude and fractional increase in TA signal
versus the concentration of SWNTs. The largest standard de-
viation of the data points, measuring 0.92 mV, was observed
at 0.75-mg /mL concentration SWNTs. The data show an ap-
proximately linear relationship between the TA signal ampli-
tude and the SWNTs’ concentration. We observe a maximum
of 140% increase in the peak-to-peak signal amplitude for
1 mg /mL SWNTs over DI water. Figure 3c displays the PA
signals from LDPE vial filled with blood and with 1 mg /mL
SWNTs. The peak-to-peak PA signal amplitudes generated by
blood, and the 1-mg /mL SWNTs are 0.220.002 and
1.320.009 V, respectively. Figure 3d shows the peak-to-
peak PA signal amplitude and fractional increase in PA signal
versus the concentration of SWNTs. The largest standard de-
viation of the data points, measuring 0.027 V, was again ob-
served at 0.75-mg /mL concentration SWNTs. The data again
show an approximately linear relationship between the PA
signal amplitude and the SWNTs’ concentration. We observe a
maximum 490% increase in the peak-to-peak signal for
1-mg /mL SWNTs over blood. In vitro tests were carried out
with SWNTs 0.1 mg /mL mixed with blood in different pro-
portions, and then PA signals were recorded. Keeping in mind
that in other applications NIR light 700–800 nm would be
used for in vivo deep tissue imaging, the light used here was
of 754 nm wavelength in the reflection mode PA imaging
system.31 A tube Silastic® laboratory tubing, Dow Corning
Corp., with 300 m, i.d. 640 m o.d. was filled with blood,
blood 90% v /v+SWNTs 10% v/v, blood 75% v /v
from various samples. A LDPE 6 mm i.d., 1 cc
Hz, and PA was done at 1064 nm wavelength.
nal Peak-to-peak PA signal
amplitude mV
. active
rea
ducer
0.5-in. active
area
transducer
0.25-in. active
area
transducer
4 — —
8 113 81
5 55 68
0 28 30
2 95 81
2 58 67
0 28 27
5 62 70
33 31btained
e at 3 G
TA sig
mV
0.25-in
a
trans
1
2
1
1
1
1
1
1
—May/June 2009  Vol. 1434
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
+
b
F
t
b
b
a
o
b
b
w
l
w
4
fi
s
fi
o
p
F
S
m
r
s
4
b
i
fi
4
a
F
a
b
p

s
s
Pramanik et al.: Single-walled carbon nanotubes as a multimodal-thermoacoustic and photoacoustic-contrast agent
J
Downloaded FroSWNTs 25% v/v, blood 50% v /v+SWNTs 50% v/v,
lood 25% v /v+SWNTs 75% v/v, and SWNTs alone.
igure 3e shows the peak-to-peak PA signal amplitudes for
hose six samples, clearly indicating that the PA signal from
lood was enhanced when SWNTs were mixed with the
lood. The experiments were carried out 10 times to get the
verage and the standard deviation. We observed a PA signal
f 1.370.09 V from a mixture of 75% SWNTs and 25%
lood, compared to a 0.440.02 V PA signal from only
lood. Therefore, when SWNTs were mixed with the blood,
e saw a 210% increase in the PA signal at 754 nm wave-
ength.
Next, LDPE vials filled with different SWNTs samples
ere imaged in two dimensions using TAT and PAT. Figures
a and 4b show the TAT cross-sectional image of a vial
lled with DI water and SWNTs, respectively, clearly demon-
trating a substantial improvement in the TA signal for the vial
lled with SWNTs both figures are shown in the same range
f the color bar. Figures 4c and 4d compare the image
rofiles along the horizontal and vertical lines dotted lines in
igs. 4a and 4b, respectively. Compared to DI water,
WNTs showed 1.9 times and 2.1 times signal improve-
ents in the TA image along the horizontal and vertical lines,
espectively normalized to DI water. These results are con-
istent with the TA data presented in Fig. 3. Figures 4e and
f show cross-sectional PAT images of the vial filled with
lood and SWNTs, respectively, showing an increased signal
n the PAT images with SWNTs compared to blood both
gures are shown in the same range of the color bar. Figures
g and 4h compare the image profiles along the horizontal
nd vertical lines along the dotted lines in Figs. 4e and
ig. 3 a TA signals at 3 GHz from a LDPE vial i.d. 6 mm, volume
mplitude and fractional increase in TA signal versus SWNTs concentr
lood and 1-mg/mL SWNTs. d Peak-to-peak PA signal amplitude an
eak PA signal amplitudes from blood mixed with various amounts o
75% v/v+SWNTs 25% v/v, 4: blood 50% v/v+SWNTs 50% v
ource was of 754 nm wavelength. A tube Silastic laboratory tubing,
ample. Color online only.ournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Use4f, respectively. Compared to blood, SWNTs showed a
6.3-fold signal improvement along the horizontal line and
5.6-fold signal improvement along the vertical line nor-
malized to blood. These results are consistent with the PA
data presented in Fig. 3. The variation in the signal improve-
ment along the horizontal and vertical directions for both TAT
and PAT is possibly due to the anisotropic spatial resolution.
Figures 4i and 4j show the reconstructed tissue-
mimicking phantom TAT images for DI water and SWNTs,
respectively. The dark spot on the image, marked with a solid
arrow, is a needle used to hold the tissue sample. The bound-
ary of the fat tissue is marked with a dashed arrow. The im-
ages clearly show greater contrast for the SWNTs-filled vial
than for the DI-water-filled vial. Figures 4k and 4l show
PAT images with blood and SWNTs, respectively, for the tis-
sue phantom. The results are similar to those obtained by TAT
imaging: the SWNT sample displays greater contrast than
blood.
The main motivation in this study was to show that
SWNTs can themselves generate both TA and PA signals. To-
ward this end, as discussed above, a nonionic, nearly neutral
SWNT solution was used for the phantom imaging because,
in the future, in vivo imaging studies will be carried out by
injecting SWNTs in solution most probably in a buffer solu-
tion with water as its main component instead of solid
SWNT powder. Our results show that SWNTs could be used
for TA/PA imaging, because the intrinsic absorption properties
of SWNTs are able to produce equivalent or stronger depend-
ing on the SWNTs concentrations TA/PA signals than a
known endogenous absorber more than water in the case of
TAT and more than blood in the case of PAT. Additionally, a
lled with DI water and 1-mg/mL SWNTs. b Peak-to-peak TA signal
c PA signals at 1064 nm wavelength from a LDPE vial filled with rat
ional increase in PA signal versus SWNTs concentration. e Peak-to-
Ts. 1: Blood only, 2: blood 90% v/v+SWNTs 10% v/v, 3: blood
blood 25% v/v+SWNTs 75% v/v, and 6: SWNTs alone. The light
orning Corp., with 300 m i.d., 640 m o.d. was used to hold the1 cc fi
ation.
d fract
f SWN
/v, 5:
Dow CMay/June 2009  Vol. 1435
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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itro when the SWNTs were mixed with blood. Thus, we
onclude that when the SWNT solution is mixed with water/
lood, it enhances the total TA/PA signal from the water/
lood. Furthermore, TA/PA signals generated by SWNTs
ould be used for imaging applications where there are no
ndogenous signals. For example, using PA imaging and
WNTs, we have carried out in vivo sentinel lymph-node
apping noninvasively.36 In this application, there was no
lood signal involved and the PA signals generated by the
WNTs were used for imaging the sentinel lymph nodes. An-
ther example is a targeted molecular imaging application,
here the TA/PA signal would be generated from the contrast
gents themselves.
As shown in previous studies,37 the optical absorption
roperties of SWNTs are strong in the visible and NIR region.
urrently, no studies have demonstrated SWNTs’ absorption
roperty in the 3-GHz microwave region, but their conductive
roperties make them promising for strong absorption.38
WNTs have high permittivity when exposed to electromag-
etic radiation at frequencies between 0.5 and 3 GHz, and as
he frequency increases to 3 GHz, the permittivity
ecreases,39,40 indicating that SWNTs could be used as con-
rast agents at 3 GHz. Another study showed the feasibility
f iron oxide nanoparticles as a contrast agent in TAT.41 To the
est of our knowledge, this is the first study that explores the
fficacy of SWNTs as contrast agents for multimodal imaging
ith TAT/PAT. This study successfully demonstrates that
ig. 4 a Cross-sectional TAT image of the vial LDPE, 6 mm i.d., 1
ontaining 1-mg/mL SWNTs. c Comparison of the signal profiles a
omparison of the signal profiles along the vertical lines across the
ontaining blood. f Cross-sectional PAT image of the vial containing
ines across the centers of the vials in e and f. h Comparison of th
nd f. i Cross-sectional TAT image of the vial containing DI wate
-mg/mL SWNTs inside pork fat tissue. The solid arrow points to t
oundary of the fat tissue. k Cross-sectional PAT image of the bloo
WNTs vial inside pork fat tissue. Color online only.ournal of Biomedical Optics 034018-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of UseSWNTs are suitable as a contrast agent for both TAT and PAT.
The SWNTs also allow contrast-enhanced deep-tissue imag-
ing with TAT. In this study, for TAT, we observed contrast
enhancement due to the SWNTs at an rf frequency of 3 GHz.
It will be particularly interesting to characterize their effec-
tiveness at lower rf frequencies. It is well known that the
human body becomes more transparent at lower rf frequen-
cies, allowing an increase in the imaging depth. However,
because of lower tissue absorbance at lower rf frequencies,
the intrinsic image contrast suffers. Therefore, if the SWNTs
work as a contrast agent at lower rf frequencies, we can po-
tentially achieve low-background, high-sensitivity, deep-
tissue imaging.
The broad absorption range of SWNTs in the visible/NIR
region37 is also beneficial for optical imaging because one can
use a wide range of laser wavelengths for imaging without the
need to tune the contrast agent to a particular wavelength to
optimize light absorption. In comparison, other contrast
agents suitable for PAT, such as gold nanoparticles, are tuned
to a particular wavelength range and can be used only with
light within that range.17,42 Furthermore, our results suggest
that a minimum detectable concentration of SWNTs should be
comparable to that of gold nanoparticles.42 Using previously
derived equations,43 we have calculated that carbon nanotubes
of 2 nm average diameter and 1 m average length have
105 carbon atoms, giving an average molecular weight of
106 Da or g/mol multiply the number of carbon atoms by
ume containing DI water. b Cross-sectional TAT image of the vial
e horizontal lines across the centers of the vials in a and b. d
of the vials in a and b. e Cross-sectional PAT image of the vial
mL SWNTs. g Comparison of the signal profiles along the horizontal
al profiles along the vertical lines across the centers of the vials in e
pork fat tissue. j Cross-sectional TAT image of the vial containing
dle used to hold the fat tissue, and the dashed arrow indicates the
inside pork fat tissue. l Cross-sectional PAT image of the 1-mg/mLcc vol
long th
centers
1-mg/
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Downloaded Fro2, the atomic weight of carbon. From Fig. 3, it is clear that
he minimum detectable concentration is 0.1 mg /mL or
00 nM 0.1 mg /mL /106 g /mol, 1 M SWNTs concentra-
ion, allowing their detection in the nM range. It is also evi-
ent that even at 0.1-mg /mL SWNTs concentration, there is a
5% increase in peak-to-peak TA signal compared to DI water
nd a 32% increase in peak-to-peak PA signal compared to
lood. For targeted molecular imaging applications, an impor-
ant consideration is not only the enhancement, but also the
ignal generated by the SWNTs themselves. In this study, we
ave detected signals with very high signal-to-noise ratio
SNR100 in both TA and PA at 1 mg /mL SWNT concen-
ration, suggesting that the minimum detectable SWNT con-
entration could be as low as 0.01 mg /mL or 10 nM with
his system, making them suitable for in vivo applications in
arious tissues. In general, the minimum detectable concen-
ration of an exogenous contrast agent by PAT/TAT is depen-
ent on many factors, such as incident light/microwave en-
rgy, ultrasound detector sensitivity, data acquisition
lectronics, etc. For our future in vivo studies, the concentra-
ions of the SWNTs will depend on the specific application
nd the sensitivity of the imaging system.36,44
The SWNTs also have a number of additional benefits. i
ther than TAT and PAT, SWNTs can also be used as a con-
rast agent for other imaging modalities, such as MRI, PET,
IR optical imaging, and nuclear imaging.22–25 Therefore, in a
rue sense they can work as a multi-modal contrast agent. ii
he external carbon sheath of the SWNTs can be directly
unctionalized for targeting and drug delivery. This capability
s not possible for other optical contrast agents, such as gold
anoparticles, where one does not functionalize the gold, but
ather the capping agents or the biocompatible coating used to
tabilize and/or dispense gold nanoparticles in solution. iii
WNTs now offer the exciting and tantalizing prospect of
chieving TAT and/or PAT molecular imaging and simulta-
eous therapy by NIR and rf-induced hyperthermia. Recently,
WNTs have been shown to facilitate the NIR and rf-induced
blation of tumor cells/tissues.25,45 Thus, these unique features
f SWNTs should allow the design of multimodal imaging
nd multitherapeutic approaches within a single platform.
Conclusions
n summary, we have successfully shown that SWNTs provide
ore than twofold signal enhancement in TAT at 3 GHz and
ore than sixfold signal enhancement in PAT at 1064 nm.
hese results indicate that by using SWNTs as contrast
gents, the functional information from TAT and PAT together
ith other structural imaging modalities will be advantageous
or early cancer diagnosis. At lower rfs, these exogenous con-
rast agents offer a new paradigm for low-background, high-
ensitivity, deep-tissue, and targeted molecular imaging by
AT.
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